960 Shares in CME Group Inc. $CME Acquired by Olympiad Research LP

Olympiad Research LP bought a new stake in shares of CME Group Inc. (NASDAQ:CME) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 960 shares of the financial services provider’s stock, valued at approximately $265,000.

Several other institutional investors have also recently made changes to their positions in CME. Advisors Capital Management LLC grew its position in shares of CME Group by 4.4% in the second quarter. Advisors Capital Management LLC now owns 108,340 shares of the financial services provider’s stock valued at $29,861,000 after purchasing an additional 4,550 shares in the last quarter. L & S Advisors Inc grew its holdings in CME Group by 158.4% during the 2nd quarter. L & S Advisors Inc now owns 36,323 shares of the financial services provider’s stock valued at $10,011,000 after buying an additional 22,268 shares in the last quarter. Donoghue Forlines LLC increased its position in shares of CME Group by 7.3% during the second quarter. Donoghue Forlines LLC now owns 15,485 shares of the financial services provider’s stock valued at $4,268,000 after buying an additional 1,048 shares during the period. Oak Harvest Investment Services lifted its holdings in shares of CME Group by 1.2% in the second quarter. Oak Harvest Investment Services now owns 25,702 shares of the financial services provider’s stock worth $7,084,000 after buying an additional 314 shares in the last quarter. Finally, Banco Bilbao Vizcaya Argentaria S.A. lifted its holdings in shares of CME Group by 36.0% in the second quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 46,760 shares of the financial services provider’s stock worth $12,883,000 after buying an additional 12,376 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. UBS Group decreased their target price on shares of CME Group from $285.00 to $280.00 and set a “neutral” rating on the stock in a report on Thursday, October 23rd. Piper Sandler upped their price target on shares of CME Group from $296.00 to $313.00 and gave the stock an “overweight” rating in a report on Thursday. Rothschild & Co Redburn boosted their target price on CME Group from $297.00 to $300.00 and gave the stock a “neutral” rating in a research report on Thursday, November 6th. Morgan Stanley raised their price target on CME Group from $312.00 to $314.00 and gave the company an “overweight” rating in a report on Thursday, October 23rd. Finally, Weiss Ratings restated a “buy (b)” rating on shares of CME Group in a research report on Wednesday, October 8th. Eight analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, CME Group currently has a consensus rating of “Hold” and an average price target of $287.06.

Insider Buying and Selling at CME Group

In other CME Group news, insider Timothy Francis Mccourt sold 379 shares of the firm’s stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total value of $98,475.57. Following the sale, the insider owned 9,508 shares of the company’s stock, valued at $2,470,463.64. This trade represents a 3.83% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director William R. Shepard acquired 262 shares of the firm’s stock in a transaction on Thursday, September 25th. The stock was purchased at an average price of $265.19 per share, for a total transaction of $69,479.78. Following the transaction, the director directly owned 258,459 shares of the company’s stock, valued at approximately $68,540,742.21. This trade represents a 0.10% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have sold a total of 14,043 shares of company stock worth $3,791,486 over the last ninety days. 0.30% of the stock is owned by company insiders.

CME Group Stock Performance

CME Group stock opened at $283.54 on Friday. The firm has a fifty day simple moving average of $266.87 and a two-hundred day simple moving average of $272.73. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a twelve month low of $222.56 and a twelve month high of $290.79. The company has a market capitalization of $102.24 billion, a PE ratio of 27.47, a P/E/G ratio of 4.41 and a beta of 0.38.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.63 by $0.05. The firm had revenue of $1.54 billion for the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The company’s quarterly revenue was down 3.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.68 earnings per share. Research analysts expect that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 12th will be issued a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date is Friday, December 12th. CME Group’s dividend payout ratio is currently 48.45%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.